Preferred Label : Taltz;
Origin ID : M000622270;
Related record
https://www.has-sante.fr/jcms/p_3478092/fr/taltz-ixekizumab-psoriasis-en-plaques-pediatrique
2024
false
false
false
France
evaluation of the transparency committee
Patch
Pediatric
bone plates
psoriasis
Taltz
Childhood-Onset Systemic Lupus Erythematosus
pediatrics
psoriasis vulgaris
Ixekizumab
ixekizumab
Psoriasis
Pediatricians
ixekizumab
pediatrician
Pediatric
---
https://www.has-sante.fr/jcms/p_3271027/fr/taltz-ixekizumab-rhumatisme-psoriasique
2021
false
false
false
France
evaluation of the transparency committee
ixekizumab
Taltz
antibodies, monoclonal, humanized
ixekizumab
treatment outcome
arthritis, psoriatic
ixekizumab
Interleukin-17
antibodies, monoclonal, humanized
---
https://www.has-sante.fr/portail/jcms/c_2847914/fr/taltz-ixekizumab-immunosuppresseur-anti-interleukine-17a
2018
false
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
ixekizumab
ixekizumab
injections, subcutaneous
treatment outcome
immunosuppressive agents
immunosuppressive agents
Interleukin-17A
Interleukin-17A
arthritis, psoriatic
drug therapy, combination
adult
insurance, health, reimbursement
ixekizumab
Taltz
Interleukin-17
Interleukin-17
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
---
